University of Illinois at Urbana-Champaign

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Illinois at Urbana-Champaign sits in the top decile of US sponsors by registered trial count (#211 of 15,742 sponsors by registered trial count).

129 total trials 18 currently recruiting 101 completed early-phase tilt top decile by trial count

University of Illinois at Urbana-Champaign: 129 sponsored US clinical trials, 18 recruiting.

University of Illinois at Urbana-Champaign sponsors 129 registered US clinical trials on ClinicalTrials.gov, 18 of them currently recruiting, and 101 completed. 2 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 5 trials.

Top-decile sponsor footprint

University of Illinois at Urbana-Champaign ranks in the top decile of sponsors by registered trial count (#211 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 80/100

101 of 105 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

129 total, page 3 of 3

COMPLETED NA

Technology-assisted Vocal Exercise for Older Adults

NCT03015870

COMPLETED NA

Water Intervention for Thinking in Kids (WITiKids ) Study

NCT02816450

COMPLETED NA

INSIGHT, A Comprehensive, Multidisciplinary Brain Training System

NCT02780739

COMPLETED Phase 1

Body Weight Supported Treadmill Training in Persons With Multiple Sclerosis

NCT01992679

COMPLETED Phase 2

Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS

NCT02457091

COMPLETED NA

FlexToBa for People With Multiple Sclerosis

NCT01993095

COMPLETED Phase 1

Fall Risk Reduction in Multiple Sclerosis: Exercise Versus Behavior

NCT01956227

COMPLETED NA

Tolerance and Utilization of Agave Inulin in Healthy Adults

NCT01925560

COMPLETED NA

Regulating Efficacy and Wellness in Diabetes

NCT01790724

COMPLETED NA

Cognitive Regulation Training and Exercise

NCT01837004

TERMINATED NA

Functional Electrical Stimulation (FES) Exercise Training in Hemodialysis Patients

NCT01956214

COMPLETED NA

Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients

NCT01837238

COMPLETED NA

The Social Media and Activity Research in Teens Trial

NCT01870323

COMPLETED

Sweet Cheeks: How Early Nutrition Affects Oral Microbiota Populations and Disease Incidence

NCT01836952

COMPLETED NA

The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition

NCT02630667

COMPLETED Phase 1

Project FARMS: Fall Risk Reduction in Multiple Sclerosis

NCT01837017

COMPLETED NA

Stretching and Yoga Exercise Study

NCT01650532

COMPLETED NA

Enhancing Children's Cognitive and Brain Health Through Physical Activity Training (FITKids2)

NCT01619826

COMPLETED NA

Fit & Active Seniors Trial

NCT01472744

COMPLETED NA

Effect of a Visual Nutrient Profiling System on Recall of Nutrition Information

NCT01486147

COMPLETED Phase 4

Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting

NCT01276691

COMPLETED NA

Medtable: An Electronic Medical Record (EMR) Strategy to Promote Patient Medication Understanding and Use

NCT01296633

COMPLETED NA

Intra Hemodialytic Oral Protein and Exercise (IHOPE)

NCT01234441

COMPLETED Phase 2

Selective Exposure in HIV Prevention

NCT01152281

COMPLETED NA

Activity, Gait, and Efficacy (AGE II): Functional Limitations and Quality of Life

NCT01030419

COMPLETED NA

Vascular and Neuro-inflammatory Effects of Endurance Exercise Training in African Americans

NCT01024634

COMPLETED Phase 1

Higher Protein Diet and Exercise for Optimal Weight Loss in Elderly Women

NCT00912210

COMPLETED Phase 3

Exercise Effects on Cognition in School-Aged Children

NCT01334359

COMPLETED

Influence of Fitness on Brain and Cognition

NCT00438347

← Previous Page 3 of 3

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 3
Phase 3 1
Phase 4 1

What is open in the University of Illinois at Urbana-Champaign pipeline

18 recruiting of 129 indexed (14% open); 101 completed (78%).

Phase mix: 2 late (III/IV) vs 8 early (I/II) (early-phase heavy).

Top condition: Multiple Sclerosis (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Illinois at Urbana-Champaign: open-pipeline peers nationwide

Peers matched on 129 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

University of Illinois at Urbana-Champaign sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20%25% Total trials Recruiting share University of Illinois at Urbana-ChampaignRhode Island HospitalJazz PharmaceuticalsNational Institute on Aging (NIA)Stony Brook UniversitySeattle Institute for Biomedical and Clinical ResearchUniversity of PennsylvaniaJohns Hopkins Bloomberg School of Public HealthMilton S. Hershey Medical Center
University of Illinois at Urbana-Champaign sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Illinois at Urbana-Champaign sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 129 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this University of Illinois at Urbana-Champaign page

129 registered trials is a research-attention snapshot, not an endorsement of University of Illinois at Urbana-Champaign or any single study.

  • 18 of University of Illinois at Urbana-Champaign's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Multiple Sclerosis is the condition University of Illinois at Urbana-Champaign studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Illinois at Urbana-Champaign pipeline card: 129 registered trials from official public datasets.Report a data error.